CannaGlobal Canada Co. Inc., Sansero Life Sciences Inc., and Rise Wellness this week announced the completion of their amalgamation to form CannaGlobal Wellness, a global psychedelics leader focused on psilocybin and other natural compounds to promote emotional, mental, and physical wellness. Sansero Life Sciences is developing psilocybin-based pharmaceutical products to treat mental health conditions, and Rise Wellness has deep clinical and scientific expertise with psilocybin, including doing important work in both Canada and Jamaica.
Steve Sadoff, CEO of CannaGlobal Wellness, said, “I’m excited to announce the completion of this transaction. This is a major milestone for our company and shareholders as we continue our ambitious journey to develop and deploy new ways to promote wellness through psilocybin and other natural compounds.
Stoic Advisory Inc. served as Financial Advisor for CannaGlobal and its Board of Directors. Wildeboer Dellelce LLP acted as legal advisors to CannaGlobal. Borden Ladner Gervais LLP (BLG) acted as legal advisor to both Sansero and Rise.
Source: Biospace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
